Avadel Pharmaceuticals (AVDL) Non-Current Assets (2016 - 2022)
Historic Non-Current Assets for Avadel Pharmaceuticals (AVDL) over the last 14 years, with Q3 2022 value amounting to $32.5 million.
- Avadel Pharmaceuticals' Non-Current Assets fell 4416.24% to $32.5 million in Q3 2022 from the same period last year, while for Sep 2022 it was $179.9 million, marking a year-over-year decrease of 1389.97%. This contributed to the annual value of $54.8 million for FY2021, which is 1368.12% up from last year.
- As of Q3 2022, Avadel Pharmaceuticals' Non-Current Assets stood at $32.5 million, which was down 4416.24% from $32.2 million recorded in Q2 2022.
- In the past 5 years, Avadel Pharmaceuticals' Non-Current Assets ranged from a high of $121.1 million in Q3 2018 and a low of $32.2 million during Q2 2022
- In the last 5 years, Avadel Pharmaceuticals' Non-Current Assets had a median value of $64.4 million in 2020 and averaged $67.3 million.
- Within the past 5 years, the most significant YoY rise in Avadel Pharmaceuticals' Non-Current Assets was 12177.68% (2018), while the steepest drop was 4938.28% (2018).
- Over the past 5 years, Avadel Pharmaceuticals' Non-Current Assets (Quarter) stood at $65.4 million in 2018, then rose by 5.51% to $69.1 million in 2019, then tumbled by 30.23% to $48.2 million in 2020, then increased by 13.68% to $54.8 million in 2021, then plummeted by 40.6% to $32.5 million in 2022.
- Its last three reported values are $32.5 million in Q3 2022, $32.2 million for Q2 2022, and $60.4 million during Q1 2022.